NEW YORK (GenomeWeb News) – Certain investors have exercised warrants to purchase 12.1 million shares of Vermillion's common stock, providing the company $17.6 million in proceeds, Vermillion said late Thursday.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: CRISPR-based approach to identify gene variants, and more.
Stat News profiles the Wellcome Trust's Jeremy Farrar.
France's research minister tells Nature News that he hopes to simplify the research bureaucracy and improve funding.
A recent study examines how a paper, despite being retracted, can influence its field, Retraction Watch reports.